RAG is supposed to make enterprise AI more accurate, but it could potentially also make it less safe according to new research.

In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at up-to-date safety data on Leqembi (lecanemab) at its next meeting in ...